Des-aspartate-angiotensin i exerts antiviral effects and attenuates ICAM-1 formation in rhinovirus-infected epithelial cells

European Journal of Pharmacology

Volumn 683, Issue 1-3, 2012, Pages 310-315

  Ang, Lay Teng ^a   Tan, Ling Yin ^a   Chow, Vincent T ^a   Sim, Meng Kwoon ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Angiotensin AT1 receptor; Des aspartate angiotensin I; E selectin; ICAM 1; Rhinovirus; Superoxide

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANTIINFLAMMATORY AGENT; ANTIVIRUS AGENT; DES ASPARTATE ANGIOTENSIN 1; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; LOSARTAN; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; CELL ASSAY; CELL DEATH; CELL SURVIVAL; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; HELA CELL; HUMAN; HUMAN CELL; LUNG ALVEOLUS EPITHELIUM; MEDIATOR; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RHINOVIRUS;

ANGIOTENSIN I; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIVIRAL AGENTS; CELL LINE; CELL SURVIVAL; CYTOPATHOGENIC EFFECT, VIRAL; E-SELECTIN; EPITHELIAL CELLS; HELA CELLS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MICROBIAL VIABILITY; OSMOLAR CONCENTRATION; RECEPTOR, ANGIOTENSIN, TYPE 1; RESPIRATORY MUCOSA; RHINOVIRUS; SUPEROXIDES;

EID: 84860471462     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2012.02.032     Document Type: Article

References (53)

1. P. Anderson, S. Alm, K. Edman, and A.M. Linberg A novel and rapid method to quantify cytolytic replication of piconariviruses in cell culture J. Virol. Meth. 130 2005 117 123
2. E. Arruda, A. Pitkaranta, T.J. Witek Jr., A. Doyle, and F.G. Hayden Frequency and natural history of rhinovirus infections in adults during autumn J. Clin. Microbiol. 35 1997 2864 2868
3. J.S. Bertino Cost burden of viral respiratory infections: issues for formulary decision makers Am. J. Med. 112 2002 32S 49S
4. S.K. Bohm, E.F. Grady, and N.W. Bunnett Regulatory mechanisms that modulate signaling by G-protein-coupled receptor Biochem. J. 322 1997 1 18
5. R.A. Garibaldi Epidemiology of community-acquired respiratory tract infections in adults. Incidence, etiology, and impact Am. J. Med. 78 1985 32 37
6. E. Gaudermak, J. Seipelt, A. Triendl, A. Grassauer, and E. Kuechler Antiviral effects of pyrrolidine dithiocarbamate on human rhinoviruses J. Virol. 76 2002 6004 6015
7. J.E. Gern, and W.W. Busse Relationship of viral infection to wheezing illnesses and asthma Nat. Rev. Immunol. 2 2002 132 138
8. S.B. Greenberg Respiratory consequences of rhinovirus infection Arch. Intern. Med. 163 2003 278 284
9. J.M. Greve, G. Davis, A.M. Meyer, C.P. Forte, S.C. Yost, C.W. Marlor, M.E. Kamarck, and A. McClelland The major human rhinovirus receptor is ICAM-1 Cell 56 1989 839 847
10. K. Grunberg, and P.J. Sterk Rhinovirus infections: induction and modulation of airways inflammation in asthma Clin. Exp. Allergy 29 Suppl. 2 1999 65 73
11. K. Grunberg, M.C. Timmers, E.P. deKlerk, E.C. Dick, and P.J. Sterk Experimental rhinovirus 16 infection causes variable airway obstruction in subjects with atopic asthma Am. J. Respir. Crit. Care Med. 160 1999 1375 1380
12. F.G. Hayden, and J.M. Gwaltney Jr. Intranasal interferon-α2 treatment of experimental rhinoviral colds J. Infect. Dis. 150 1984 174 180
13. F.G. Hayden, D.L. Kaiser, and J.K. Albrecht Intranasal recombinant alfa-2b interferon treatment on naturally occurring common colds Antimicrob. Agents Chemother. 32 1988 224 230
14. C.L. Heldt, R. Hernandez, U. Mudiganti, P.V. Gurgel, D.T. Brown, and R.G. Carbonell A colorimetric assay for viral agents that produce cytopathic effects J. Virol. Meth. 135 2006 56 65
15. Z.H. Huang, E.J. Bates, J.V. Ferrante, C.S.T. Hii, A. Poulos, B.S. Robinson, and A. Ferrante Inhibition of stimulus-induced endothelial cell intercellular adhesion molecule-1, E-selectin and vascular cellular adhesion molecule-1 expression by arachidonic acid and its hydroxy and hydroperoxy derivatives Circ. Res. 80 1997 149 158
16. Y.J. Jang, J.H. Wang, J.S. Kim, H.J. Kwon, N.K. Yeo, and B.J. Lee Levocetirizine inhibits rhinovirus-induced ICAM-1 and cytokine expression and viral replication in airway epithelial cells Antivir. Res. 81 2009 226 233
17. S.L. Johnston Natural and experimental rhinovirus infections of the lower respiratory tract Am. J. Respir. Crit. Care Med. 152 1995 S46 S52
18. P. Kaul, M.C. Biaglioli, and I. Singh Rhinovirus-induced oxidative stress and interleukin-8 elaboration involves p47-phox but is independent of attachment to intercellular adhesion molecule-1 and viral replication J. Infect. Dis. 181 2000 1885 1890
19. J. Kim, S.P. Sanders, E.S. Siekierski, V. Casolaro, and D. Proud Role of NF-kappa B in cytokine production induced from human airway epithelial cell by rhinovirus infection J. Immunol. 165 2000 3384 3392
20. V. Laza-Stanca, L.A. Stanclu, S.D. Message, M.R. Edwards, J.E. Geern, and S.L. Johnston Rhinovirus replication in human macrophages induces NF-κB-dependent tumor necrosis factor alpha production J. Virol. 80 2006 8248 8258
21. M. Lieber, B. Smith, A. Szakai, W. Nelson-Rees, and G. Todaro A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells Int. J. Cancer 17 1976 62 70
22. D.A. Matthews, P.S. Dragovinch, S.E. Webber, S.A. Fuhrman, A.K. Patick, L.S. Zalman, T.F. Hendrickson, R.A. Love, T.J. Prins, J.T. Marakovits, R. Zhou, J. Tikhe, G.E. Ford, J.W. Meador, R.A. Ferre, E.L. Brown, S.L. Bindord, M.A. Brothers, D.K. DeLisle, and S.T. Worland Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes Proc. Natl. Acad. Sci. U. S. A. 96 1999 11000 11007
23. M. Mattson Hormesis defined Ageing Res. Rev. 7 2008 1 7
24. E.K. Miller, X. Lu, D.D. Erdman, K.A. Poehling, Y. Zhu, M.R. Griffin, T.V. Hartert, L.J. Anderson, G.A. Weinberg, C.B. Hall, M.K. Iwane, and K.M. Edwards Rhinovirus-associated hospitalizations in young children J. Infect. Dis. 195 2007 773 781
25. E.T. Ng, M.K. Sim, and W.K. Loke Protective actions of des-aspartate-angiotensin I in mice model of CEES-induced lung intoxication J. Appl. Toxicol. 2010 10.1002/jat.1599 2010 Nov 9. [Epub ahead of print]
26. K.G. Nicholson, J. Kent, and D.C. Ireland Respiratory viruses and exacerbations of asthma in adults BMJ 307 1993 982 986
27. A. Papi, N.G. Papadopoulos, L.A. Stanciu, C.M. Bellettato, S. Pinamonti, K. Degtiz, S.T. Holgate, and S.L. Johnston Reducing agents inhibit rhinovirus-induced up-regulation of rhinovirus receptor intracellular adhesion molecule-1 (ICAM-1) in respiratory epithelial cells FASEB 16 2002 1934 1936
28. A. Papi, M. Contoli, P. Gasparini, L. Bristot, M.R. Edwards, M. Chicca, M. Leis, A. Ciaccia, G. Caramori, S.L. Johnston, and S. Pinamonti Role of xanthine oxidase activation and reduced glutathione depletion in rhinovirus induction of inflammation in respiratory epithelial cells J. Biol. Chem. 283 2008 28595 28606
29. 1 mediates alveolar epithelial cell apoptosis in response to ANG II Am. J. Physiol. Lung Cell. Mol. Physiol. 282 2002 L713 L718
30. D.C. Pevear, F.G. Hayden, T.M. Demencsuk, L.R. Barone, M.A. McKinlay, and M.S. Collett Relationship of pleconaril susceptibility and clinical outcomes in treatment of common colds caused by rhinoviruses Antimicrob. Agents Chemother. 44 2005 1236 1241
31. A. Pitkarata, and F.G. Hayden Rhinoviruses: important respiratory pathogens Ann. Med. 30 1998 529 537
32. C. Savolainen, S. Blonmqvist, M.N. Mulders, and T. Hovi Genetic clustering of all 102 human rhinovirus prototypes strains: serotype 87 is a close to human enterovirus 70 J. Gen. Virol. 83 2002 333 340
33. R. Schreck, B. Meier, D.N. Mannel, W. Droge, and P.A. Baeuerle Dithiocarbamates as potent inhibition of nuclear factor kappa B activation in intact cells J. Exp. Med. 175 1992 1181 1194
34. R. Schreck, K. Albermann, and P.A. Baeuerle Nuclear factor kappa B: an oxidative stress-responsive transcription factor of eukaryotic cells Free. Radic. Res. Commun. 17 1992 221 237
35. S.K. Sethi, A. Bianco, J.T. Allen, R.A. Knight, and M.A. Spiteri Interferon-gamma (IFN-γ) down-regulates the rhinovirus-induced expression of intercellular adhesion molecule-1 (ICAM-1) on human airway epithelial cells Clin. Exp. Immunol. 110 1997 362 369
36. M. She, J. Li, K. Guo, W. Lin, X. Du, and X. Niu Requirement of reactive oxygen species generation in apoptosis of leukemia cells induced by 2-methoxyestradiol Acta Pharmacol. Sin. 28 2007 1037 1044
37. M.K. Sim, and S.K. Chai Subtypes of losartan-sensitive angiotensin receptor in the rabbit pulmonary artery Br. J. Pharmacol. 117 1996 1504 1506
38. M.K. Sim, and L. Min Effects of des-Asp-angiotensin I on experimentally-induced cardiac hypertrophy in rats Int. J. Cardiol. 63 1998 223 227
39. M.K. Sim, X.G. Xu, Y.C. Wong, S.Z. Sim, and K.O. Lee Des-aspartate- angiotensin I exerts hypoglycemic action via glucose transporter-4 translocation in type 2 diabetes KKAy mice and GK rats Endocrinology 148 2007 5925 5932
40. T. Suzuki, M. Yamaya, K. Sekizawa, M. Hosoda, N. Yamada, S. Ishizuka, A. Yoshino, H. Yasuda, H. Takahashi, H. Nishimura, and H. Sasaki Erythromycin inhibits rhinovirus infection in cultured human tracheal epithelial cells Am. J. Respir. Crit. Care 165 2002 1113 1118
41. A. Tanaka, A. Matsumori, W. Wang, and S. Sasayama An angiotensin I receptor antagonist reduces myocardial damage in an animal model of myocarditis Circulation 90 1994 2051 2055
42. M. Terajima, M. Yamaya, K. Seikzawa, S. Oinaga, T. Suzuki, N. Yamada, K. Nakayama, T. Ohrui, T. Oshima, Y. Numazaki, and H. Sasaki Rhinovirus infection of primary cultures of human tracheal epithelium: role of ICAM-1 and IL-1β Am. J. Physiol. Lung Cell. Mol. Physiol. 280 2001 L115 L1127
43. P.B. Timmermans, P.C. Wong, A.T. Chiu, W.F. Herblin, P. Benfield, D.J. Carini, R.J. Lee, R.R. Wexler, J.A. Saye, and R.D. Smith Angiotensin II receptors and angiotensin II receptor antagonists Pharmacol. Rev. 45 1993 205 251
44. R.B. Turner, M.T. Wecker, G. Pohl, T.J. Witek, E. McNally, R. St. George, B. Winters, and F.G. Hayden Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection J. Am. Med. Assoc. 281 1999 1797 1804
45. Q. Wen, and M.K. Sim Effects of des-aspartate-angiotensin I on myocardial ischemia-reperfusion injury in rats Eur. J. Pharmacol. 658 2011 193 199
46. Q. Wen, M.K. Sim, and F.R. Tang Reduction of infarct size by orally administered des-aspartate-angiotensin I in the ischemic reperfused rat heart Regul. Pept. 120 2004 149 153
47. S.C. Whiteman, A. Bianco, R.A. Knight, and M.A. Spiteri Human rhinovirus selectively modulates membranous and soluble forms of its intercellular adhesion molecule-1 (ICAM-1) receptor to promote epithelial cell infectivity J. Biol. Chem. 278 2003 11954 11961
48. P. Wongprompitak, S. Sirisinha, and S.C. Chaiyaroj Differential gene expression profiles of lung epithelial cells exposed to Burkholderia pseudomallei and Burkholderia thailandensis during the initial phase of infection Asian Pac. J. Allergy Immunol. 26 2008 59 70
49. M. Xatzipsalti, and N.G. Papadopoulos Cellular and animals models for rhinovirus infection in asthma Contrib. Microbiol. 14 2007 33 41
50. K. Yamamoto, T. Shioi, K. Uchiyama, T. Miyamoto, S. Sasayama, and A. Matsumori Attenuation of virus-induced myocardial injury by inhibition of the angiotensin II type 1 receptor signal and decrease nuclear factor-kappa B activation in knockout mice J. Am. Coll. Cardiol. 42 2003 2000 2006
51. M. Yamaya, and H. Sasaki Rhinovirus and asthma Viral Immunol. 16 2003 99 109
52. Y.T. Yen, F. Liao, C.H. Hsiao, C.L. Kao, Y.C. Chen, and B.A. Wu-Hsieh Modeling the early events of severe acute respiratory syndrome coronavirus infection in vitro J. Virol. 80 2006 2684 2693
53. J. Zhang, S.S. Ferguson, L.S. Barak, L. Ménard, and M.G. Caron Dynamin and β-arrestin reveal distinct mechanisms for G protein-coupled receptor internalization J. Biol. Chem. 271 1996 18302 18305